A Study of MGD020 Alone or Combined With MGD014 in Persons With HIV-1 on Antiretroviral Therapy

NCT05261191 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

17

Enrollment

INDUSTRY

Sponsor class

Conditions

Human Immunodeficiency Virus I Infection
Immunodeficiency Virus Type 1, Human
Human Immunodeficiency Virus Type 1

Interventions

BIOLOGICAL: MGD020
BIOLOGICAL: MGD014

Sponsor

MacroGenics

Collaborators

[object Object]
[object Object]
[object Object]